RecruitingNCT05656469
This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
AnxietyOtherFrom 16 Years to 65 Years
- Countries
- Germany, Netherlands, Romania, Serbia, Spain, United Kingdom, United States
- Sponsor
- Maastricht University Medical Center
- Condition
- Anxiety
RecruitingNCT05185128
This study is looking at whether PEERS social skills intervention can help people with Autism Spectrum Disorder, Psychosis, or Social Communication. Participants take part in PEERS social skills intervention and complete follow-up assessments.
SchizophreniaOtherFrom 12 Years to 18 Years
- Countries
- United States
- Sponsor
- Loma Linda University
- Condition
- Schizophrenia
RecruitingNCT06672588
This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health
- Condition
- Schizophrenia
RecruitingNCT07383324
This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 85 Years
- Countries
- Canada
- Sponsor
- University of Ottawa
- Condition
- Schizophrenia
RecruitingNCT06456983
This study is looking at whether maintenance electroconvulsive therapy (mECT) can help people with Schizophrenia or Treatment Resistant Schizophrenia. Participants take part in maintenance electroconvulsive therapy (mECT) and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Mannheim
- Condition
- Schizophrenia
RecruitingNCT07177261
This study is looking at care and outcomes for people with Schizophrenia Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
RecruitingNCT07378150
This study is looking at whether Clay therapy can help people with Schizophrenia and Related Disorders. Participants take part in Clay therapy and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Turkey
- Sponsor
- Kutahya Health Sciences University
- Condition
- Schizophrenia
RecruitingNCT07184619
This study is comparing Evenamide 15 mg bid with placebo for people with Treatment-resistant Schizophrenia. Participants receive Evenamide 15 mg bid or placebo and complete study visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Newron Pharmaceuticals SPA
- Condition
- Schizophrenia
RecruitingNCT03995121
This observational study is following people with Schizophrenia and Other psychosis, Cannabis Use Disorder, or Healthy to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 85 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT06286202
This study is looking at whether a digital support tool can help people with Schizophrenia or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherFrom 21 Years to 60 Years
- Countries
- Singapore
- Sponsor
- Singapore Institute of Technology
- Condition
- Schizophrenia
RecruitingNCT06568081
This observational study is looking at how a digital support tool works for people with Schizophrenia Spectrum and Other psychosis or Affective Psychoses in routine care. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
RecruitingNCT05208190
This observational study is following people with Schizophrenia or schizoaffective disorder to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
RecruitingNCT07098169
This study is comparing iTEST with Active Control for people with Schizophrenia Disorders, schizoaffective disorder, or psychosis. Participants receive iTEST or Active Control and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
RecruitingNCT07363577
This study is comparing LB-102 (50 mg tablet) with placebo for people with Schizophrenia. Participants receive LB-102 (50 mg tablet) or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- LB Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT04370730
This observational study is following people with Schizophrenia or psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOtherFrom 7 Years to 20 Years
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Condition
- Schizophrenia
RecruitingNCT05671185
This study is looking at whether a digital support tool can help people with Schizophrenia and Related Disorders. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 20 Years
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
- Condition
- Schizophrenia
RecruitingNCT07360665
This study is looking at whether Physical Exercise can help people with severe mental illness. Participants take part in Physical Exercise and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Portugal
- Sponsor
- University of Trás-os-Montes and Alto Douro
- Condition
- Schizophrenia
RecruitingNCT06749444
This study is looking at whether cognitive behavioural therapy can help people with Treatment-refractory Schizophrenia or Treatment-resistant Schizophrenia. Participants take part in cognitive behavioural therapy and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- Denmark
- Sponsor
- Jimmi Nielsen
- Condition
- Schizophrenia
RecruitingNCT05316883
This observational study is following people with Schizophrenia or Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- Denmark
- Sponsor
- Jimmi Nielsen
- Condition
- Schizophrenia
RecruitingNCT07343193
This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- University Hospital, Strasbourg, France
- Condition
- Schizophrenia
RecruitingNCT07344948
This observational study is following people with Healthy Participants or Schizophrenia Diagnosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Neurosterix
- Condition
- Schizophrenia
RecruitingNCT07225712
This study is looking at whether SEP-363856 can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Japan
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Condition
- Schizophrenia
RecruitingNCT05349513
This study is looking at whether questionnaires and follow-up can help people with With Schizophrenia-like Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- France
- Sponsor
- Centre Hospitalier Henri Laborit
- Condition
- Schizophrenia
RecruitingNCT06961968
This study is comparing iloperidone with placebo for people with Schizophrenia. Participants receive iloperidone or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanda Pharmaceuticals
- Condition
- Schizophrenia
RecruitingNCT05276050
This observational study is following people with Smoking Cessation, Nicotine Addiction, or Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 22 Years to 65 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia